Omnicell, Inc provides medication and supply dispensing automation, central pharmacy automation, analytics software, and medication adherence solutions for the healthcare industry worldwide. It operates in two segments, Automation and Analytics, and Medication Adherence. The Automation and Analytics segment offers central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System, a building block of autonomous pharmacy vision; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems.
Read More…
Industry, Sector and Symbol
Industry Electronic computers
Sub-IndustryHealth Care Technology
SectorMedical
Phone650-251-6100
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$787.31 million
Profitability
Miscellaneous
Employees2,480
Next Earnings Date10/24/2019 (Estimated)
OptionableOptionable
Omnicell (NASDAQ:OMCL) Frequently Asked Questions
What is Omnicell's stock symbol?
Omnicell trades on the NASDAQ under the ticker symbol "OMCL."
How were Omnicell's earnings last quarter?
Omnicell, Inc. (NASDAQ:OMCL) announced its quarterly earnings data on Thursday, July, 25th. The company reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.47 by $0.04. The business earned $217.40 million during the quarter, compared to the consensus estimate of $214.13 million. Omnicell had a return on equity of 11.85% and a net margin of 5.70%. Omnicell's revenue for the quarter was up 15.2% on a year-over-year basis. During the same period in the prior year, the company earned $0.46 EPS. View Omnicell's Earnings History.
When is Omnicell's next earnings date?
What guidance has Omnicell issued on next quarter's earnings?
Omnicell updated its FY19 earnings guidance on Thursday, July, 25th. The company provided earnings per share (EPS) guidance of $2.65-$2.82 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.77. The company issued revenue guidance of $886-$900 million, compared to the consensus revenue estimate of $891.96 million.
What price target have analysts set for OMCL?
7 Wall Street analysts have issued 1-year target prices for Omnicell's shares. Their forecasts range from $61.00 to $90.00. On average, they anticipate Omnicell's share price to reach $80.29 in the next twelve months. This suggests a possible upside of 7.2% from the stock's current price. View Analyst Price Targets for Omnicell.
What is the consensus analysts' recommendation for Omnicell?
7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Omnicell in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Omnicell.
Has Omnicell been receiving favorable news coverage?
News articles about OMCL stock have trended somewhat positive this week, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Omnicell earned a coverage optimism score of 1.8 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for Omnicell.
Who are some of Omnicell's key competitors?
What other stocks do shareholders of Omnicell own?
Who are Omnicell's key executives?
Omnicell's management team includes the folowing people:
- Mr. Randall A. Lipps, Founder, Exec. Chairman, Pres & CEO (Age 62)
- Mr. Peter J. Kuipers, Exec. VP & CFO (Age 47)
- Mr. Daniel S. Johnston, Exec. VP, Chief Legal & Admin. Officer and Corp. Sec. (Age 55)
- Mr. Joseph Brian Spears, VP of Corp. Fin. & Chief Accounting Officer (Age 59)
- Mr. Nhat H. Ngo, Exec. VP of Marketing, Strategy & Bus. Devel. (Age 46)
Who are Omnicell's major shareholders?
Omnicell's stock is owned by many different of institutional and retail investors. Top institutional investors include Tributary Capital Management LLC (0.65%), Peregrine Capital Management LLC (0.65%), Summit Creek Advisors LLC (0.53%), Scout Investments Inc. (0.44%), Rhenman & Partners Asset Management AB (0.22%) and West Coast Financial LLC (0.13%). Company insiders that own Omnicell stock include Dan S Johnston, Gary S Petersmeyer, James T Judson, Joanne B Bauer, Jorge R Taborga, Joseph Brian Spears, Nhat H Ngo, Peter J Kuipers, Randall A Lipps, Robin Gene Seim and Scott Peter Seidelmann. View Institutional Ownership Trends for Omnicell.
Which major investors are selling Omnicell stock?
OMCL stock was sold by a variety of institutional investors in the last quarter, including Pwmco LLC, Scout Investments Inc., Rhenman & Partners Asset Management AB, Tributary Capital Management LLC and CIBC Private Wealth Group LLC. Company insiders that have sold Omnicell company stock in the last year include Dan S Johnston, Gary S Petersmeyer, James T Judson, Joanne B Bauer, Jorge R Taborga, Joseph Brian Spears, Nhat H Ngo, Peter J Kuipers, Randall A Lipps and Scott Peter Seidelmann. View Insider Buying and Selling for Omnicell.
Which major investors are buying Omnicell stock?
OMCL stock was purchased by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, Summit Creek Advisors LLC, Bowling Portfolio Management LLC, State of Alaska Department of Revenue, Assenagon Asset Management S.A. and West Coast Financial LLC. View Insider Buying and Selling for Omnicell.
How do I buy shares of Omnicell?
Shares of OMCL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Omnicell's stock price today?
One share of OMCL stock can currently be purchased for approximately $74.86.
How big of a company is Omnicell?
Omnicell has a market capitalization of $3.12 billion and generates $787.31 million in revenue each year. The company earns $37.73 million in net income (profit) each year or $1.53 on an earnings per share basis. Omnicell employs 2,480 workers across the globe.View Additional Information About Omnicell.
What is Omnicell's official website?
How can I contact Omnicell?
Omnicell's mailing address is 590 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. The company can be reached via phone at 650-251-6100 or via email at [email protected]
MarketBeat Community Rating for Omnicell (NASDAQ OMCL)
MarketBeat's community ratings are surveys of what our community members think about Omnicell and other stocks. Vote "Outperform" if you believe OMCL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OMCL will underperform the S&P 500 over the long term. You may vote once every thirty days.
